Purchase Order 75F40126P00071

The Department of Health and Human Services Food and Drug Administration awarded a $22,766 purchase order to Nanostring Technologies, Inc. for the procurement of Nanostring cassettes and reagents. The firm fixed price contract has a period of performance from August 15, 2023 through August 14, 2024 and will be performed in Silver Spring, Maryland. The award is set aside for total small businesses. As the prime contractor, Nanostring will provide its proprietary gene expression analysis...

<p>The Food and Drug Administration issued a $33,175 delivery order to Pacific Biosciences of California, Inc. on August 29, 2023, for sequencing reagents and supplies including AmpureXP, HiFi Express template prep kit, Sequel binding kit, Sequel sequencing kit, and SMRT cell trays.</p> <p>Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of March 30, 2024. No set-aside was used.</p>

<p>The Food and Drug Administration awarded a purchase order to Drug Information Association, Inc. for $113,044.00 on June 14, 2026, to support the DIA Global Annual Meeting. Place of performance is Silver Spring, Maryland. The order carries a firm fixed price structure with an ultimate completion date of June 18, 2026.</p>

<p>The Food and Drug Administration issued a delivery order to the National Academy of Sciences on June 1, 2026, with a ceiling value of $1,116,650.54 under a cost-no-fee pricing structure for a Substandard and Falsified Medical Products Workshop.</p> <p>Place of performance is Berwyn Heights, MD 20740. The order extends through May 31, 2031. No set-aside applies to this delivery order.</p>

The Food and Drug Administration issued a purchase order to Creighton University for $154,452.00 on September 23, 2024. This is a no-cost modification extending the period of performance to March 13, 2026. Work is performed in Silver Spring, Maryland. The order funds further investigation of the association between β-lactamase enzyme expression and other proteins and antimicrobial resistance by studying additional gram-negative bacterial isolates. Pricing is firm fixed price with no small...

The Food and Drug Administration issued a purchase order to Cytherian LLC for transcription services valued at $96,804.02, awarded September 15, 2020. The order is firm fixed price with no set-aside category. Work is performed in Rockville, Maryland. Services support the Center for Biologics Evaluation and Research, Division of Scientific Advisors and Consultants. The order carried an ultimate completion date of September 29, 2022, and includes FDA three-way-matching invoice requirements.

<p>The Food and Drug Administration issued a delivery order to Government Scientific Source Inc., a for-profit small business, on May 27, 2026, with a ceiling value of $35,918.40, under the GSA Multiple Award Schedule (MAS) for PacBio reagents and supplies.</p> <p>Place of performance is Reston, VA 20191. The order has a firm fixed price and an ultimate completion date of September 30, 2026. No set-aside was used.</p>

The Food and Drug Administration issued a delivery order to Pacific Biosciences of California, Inc. on July 24, 2023, with a ceiling value of $61,236.00 for specialized sequencing reagents and supplies including AmpurePB, barcoded overhang adapter kits, Sequel binding and internal control kits, Sequel pipet tips, sequencing kits, SMRT cell oil, SMRT cell trays, and SMRTbell express template preparation supplies. Place of performance is Silver Spring, MD 20993. The order was firm fixed price...

<p>The Food and Drug Administration issued a $251,730.45 delivery order to Dnanexus, Inc. on May 28, 2026, under a Total Small Business set-aside for operations and maintenance of the FY26 PrecisionFDA public instance.</p> <p>Place of performance is Rockville, MD. The order is firm fixed price with an ultimate completion date of May 27, 2027.</p>

The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...